Zepbound , containing the active ingredient tirzepatide , is a newer medication that acts on both the GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors
That said, some people who struggle with exercise find that GLP-1 therapy creates an indirect exercise benefit
At the same time, cardiologists are closely following the research and exploring treatment for certain populations
These shifts in your microbiome can influence stool consistency and frequency, especially during the first few weeks when your body is adjusting to the medication
Insulin therapy alone is often not enough for people with T1D to achieve glucose and metabolic control
A capsule, by contrast, needs to dissolve first a process that can take 1530 minutes before absorption even begins